Correlation Between Pro Dex and Predictive Oncology

Can any of the company-specific risk be diversified away by investing in both Pro Dex and Predictive Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pro Dex and Predictive Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pro Dex and Predictive Oncology, you can compare the effects of market volatilities on Pro Dex and Predictive Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pro Dex with a short position of Predictive Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pro Dex and Predictive Oncology.

Diversification Opportunities for Pro Dex and Predictive Oncology

-0.45

Correlation Coefficient

Pro Dex  Predictive Oncology

Very good diversification

The 3 months correlation between Pro and Predictive is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding Pro Dex and Predictive Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Predictive Oncology and Pro Dex is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pro Dex are associated (or correlated) with Predictive Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Predictive Oncology has no effect on the direction of Pro Dex i.e., Pro Dex and Predictive Oncology go up and down completely randomly.

Pair Corralation between Pro Dex and Predictive Oncology

Given the investment horizon of 90 days Pro Dex is expected to generate 1.21 times more return on investment than Predictive Oncology. However, Pro Dex is 1.21 times more volatile than Predictive Oncology. It trades about 0.04 of its potential returns per unit of risk. Predictive Oncology is currently generating about 0.03 per unit of risk. If you would invest  4,411  in Pro Dex on May 27, 2025 and sell it today you would earn a total of  192.00  from holding Pro Dex or generate 4.35% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Pro Dex  vs.  Predictive Oncology

Pro Dex

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Pro Dex are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain technical and fundamental indicators, Pro Dex may actually be approaching a critical reversion point that can send shares even higher in September 2025.

Predictive Oncology

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Predictive Oncology are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite fairly conflicting basic indicators, Predictive Oncology may actually be approaching a critical reversion point that can send shares even higher in September 2025.

Pair Trading with Pro Dex and Predictive Oncology

The main advantage of trading using opposite Pro Dex and Predictive Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pro Dex position performs unexpectedly, Predictive Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Predictive Oncology will offset losses from the drop in Predictive Oncology's long position.

The idea behind Pro Dex and Predictive Oncology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.